Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Anacor Pharmaceutical revenue
Anacor Pharmaceutical's revenue is $82.4 million.
What is Anacor Pharmaceutical's revenue?
- Anacor Pharmaceutical has 100 employees, and the revenue per employee ratio is $823,550.
- Anacor Pharmaceutical peak revenue was $82.4M in 2024.
On this page
Zippi applies for you, and finds you a job.
Anacor Pharmaceutical financing
Anacor Pharmaceutical received early financing of $2.9M on 2002-07-24.
| Series | Round size | Date |
|---|---|---|
| Series A | $2.9M | 07/2002 |
| Series Unknown | $4M | 11/2002 |
| Series C | $25M | 05/2005 |
| Series Unknown | $50M | 02/2007 |
| Series E | $50M | 01/2009 |
| Series Unknown | $15M | 07/2010 |
| Grant | $1.5M | 11/2010 |
| Post Ipo Equity | $5M | 04/2013 |
| Post Ipo Debt | $45M | 06/2013 |
Anacor Pharmaceutical investors
| Investors | Security type |
|---|---|
| Rho Ventures | Series A |
| Aberdare Ventures | Series A |
| Rho Ventures | Series Unknown |
| Aberdare Ventures | Series Unknown |
| Red Abbey Venture Partners | Series C |
| Rho Ventures | Series C |
| Venrock | Series C |
| Care Capital | Series C |
| Aberdare Ventures | Series C |
| Schering AG | Series Unknown |
| Rho Ventures | Series E |
| Schering AG | Series E |
| Venrock | Series E |
| Care Capital | Series E |
| Aberdare Ventures | Series E |
| GlaxoSmithKline plc | Series E |
| GlaxoSmithKline plc | Series Unknown |
| U.S. Department of the Treasury | Grant |
| HERCULES CAPITAL INC | Post Ipo Debt |
Anacor Pharmaceutical competitors
Anacor Pharmaceutical's top competitor, Hoffmann-LA Roche Inc, earned an annual revenue of $60.9B.
Anacor Pharmaceutical's smallest competitor is Discovery Labs with revenue of $144.8K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cerexa Inc. | $46,963 | $1.3M | 29 | - |
| Good Start Genetics | $45,085 | $1.9M | 37 | 1 |
| SIGA Technologies | $71,494 | $115.5M | 43 | 1 |
| Hoffmann-LA Roche Inc | $93,461 | $60.9B | 101,200 | 170 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | - |
| Emisphere Technologies | $71,999 | $1.2M | 76 | - |
| Pharmaceutical Product Development | $69,995 | $65.0M | 21,000 | - |
| Discovery Labs | $71,667 | $144.8K | 119 | - |
| Karyopharm | $107,666 | $145.2M | 442 | 1 |
| PTC Therapeutics | $92,986 | $806.8M | 517 | 20 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Anacor Pharmaceutical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Anacor Pharmaceutical. The employee data is based on information from people who have self-reported their past or current employments at Anacor Pharmaceutical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Anacor Pharmaceutical. The data presented on this page does not represent the view of Anacor Pharmaceutical and its employees or that of Zippia.
Anacor Pharmaceutical may also be known as or be related to ANACOR PHARMACEUTICALS, INC., Anacor Pharmaceutical, Anacor Pharmaceuticals and Anacor Pharmaceuticals, Inc.